The present invention relates to endovascular stents, and in particular, but not being limited to, adjustable and retrievable endovascular stents.
In this specification where a document, act or item of knowledge is referred to or discussed, this reference or discussion is not an admission that the document, act or item of knowledge or any combination thereof was at the priority date, publicly available, known to the public, part of common general knowledge; or known to be relevant to an attempt to solve any problem with which this specification is concerned.
An important development in neurovascular medicine has been the ability to treat defects in relatively small arteries and veins, such as those in the neurovascular system, by use of a guiding catheter and the placement of embolic coils (or the like) in areas where an aneurysm is likely to cause (or has already caused) a rupture in the blood vessel. When the aneurysm is in the brain, it is often difficult to treat small defects in the blood vessels with conventional surgical techniques.
One aspect of these surgical treatments is that an aneurysm (or other malformation) is symptomatic of a general weakening of the vasculature in the area containing the aneurysm. Mere treatment of the aneurysm does not necessarily prevent a subsequent rupture in the surrounding area of the vessel. When a vaso-occlusive device (e.g. an embolic coil) is placed in an aneurysm, it can be difficult to prevent the migration of these small devices away from the aneurysm, particularly where the aneurysm has a relatively large neck to dome ratio. If such migration occurs, the vaso-occlusive device may cause a blockage at another part of a blood vessel, which could result in the patient having a stroke.
Stents, which are typically tubular reinforcements inserted into a blood vessel to provide an open path within the blood vessel, have been widely used in intravascular angioplasty treatment of narrowed cardiac arteries. A stent may be inserted after an angioplasty procedure in order to prevent restenosis of the artery. In such applications, stents are often deployed by use of inflatable balloons, or mechanical devices which force the stent open, thereby reinforcing the artery wall in the clear through-path in the centre of the artery after the angioplasty procedure to prevent restenosis. Although such procedures may be useful in certain aspects of vascular surgery in which vaso-occlusive devices are used, the weakness of the vasculature and the inaccessibility of the interior of the aneurysm from the vessel after the placement of such a stent, places limits on the applicability of such stents in procedures to repair aneurysms, particularly cerebral aneurysms. Furthermore, the use of placement techniques, such as balloons or mechanical expansions (e.g. of the type often found to be useful in cardiac surgery) are less useful and more dangerous (e.g. easier to cause damage or rupture) when such devices are used to treat more fragile vessels (e.g. those found in the brain).
Stenting of the intracranial circulation requires formal anticoagulation and antiplatelet therapy to maintain patency for a permanent endoprosthesis. Stenting in the intracranial circulation may be performed for unruptured cerebral aneurysms to allow reinforcement of the aneurysm neck to allow coiling of an anatomically unfavourable (e.g. a poor dome to neck ratio) aneurysm. In the case of a ruptured aneurysm, the anticoagulation and antiplatelet therapy required to maintain patency of the stent would expose the patient to an unacceptably high risk of death with a further rupture, and stenting is therefore generally not desirable for acutely ruptured aneurysms for this reason. Another device which can be used is a compliant balloon (so called balloon remodelling technique), but this device necessitates occlusion of the parent vessel with a risk of embolism and stroke.
It is desired to address one or more of the above problems, or to at least provide a useful alternative to existing stents.
According to the present invention, there is provided an endovascular stent, including:
a guide portion and a drive portion;
a plurality of flexible support arms, each including two opposing ends that are coupled to said guide portion and said drive portion respectively, said arms being moveable relative to each other between an expanded position and a compressed position; and
said stent including at least one barrier portion, such that when said arms are moved to said expanded position, said arms configure the barrier portion into a selectively permeable barrier through which one or more articles may be introduced into a space between said barrier and a wall of a lumen receiving said stent.
The present invention also provides a method for introducing a vaso-occlusive device into an aneurysm of a lumen using a stent (as described above), including:
i) positioning said stent in said lumen adjacent to said aneurysm;
ii) adjusting said arms to said expanded position to form the permeable barrier having one or more an openings adjacent to a neck of said aneurysm; and
iii) delivering said device through the openings into said aneurysm;
wherein, after said device is released into said aneurysm, said barrier inhibits movement of said device away from said aneurysm.
Representative embodiments of the present invention are herein described, by way of example only, with reference to the accompanying drawings, wherein:
A representative embodiment of an adjustable endovascular stent 100, as shown in
Each of the support arms 106 has two opposing end portions 106a and 106b that are coupled to the guide portion 102 and drive portion 104 respectively. The support arms 106 are moveable relative to each other between an expanded position and a compressed position.
The number of support arms 106 included in different stents 100 (or in the various sections/portions of the stent) may vary depending upon the type of functional characteristics to be provided by a particular stent 100. For example, a stent 100 may have fewer support arms 106 to improve the ability for a fluid (e.g. blood) to flow through the lumen in which the stent 100 is received. Alternatively, a stent 100 may have a greater number of support arms 106 for providing better support of the lumen wall, and/or for providing a more effective barrier that helps inhibit the movement of an article (e.g. a vaso-occulsive device such as an embolic coil) introduced into a space between the stent 100 and the lumen wall. For example, when the support arms 106 are configured to the expanded position, the gaps formed between adjacent arms 106 are smaller than the article so that the position of the arms 106 for an effective barrier for inhibiting the movement of the article away from its position between the stent 100 and the lumen wall.
In one representative embodiment, as shown in
The representative embodiments of the stent 100 shown in
The stent 100 as shown in
The stent 100 as shown in
In a representative embodiment, the support arms 106 are biased to move towards an expanded position, due to the flexible and spring-like properties of the support arms 106, which may be shaped with a bow-like curvature. The respective ends 106a and 106b of the support arms 106 are securely coupled to the guide portion 102 and drive portion 104 of the stent 100 by different crimp tubes 110 and 112. Alternatively, the support arms 106 can be welded to guide portion 102 and drive portion 104. This coupling configuration holds the ends 106a and 106b of the support arms 106 together and allows a centre portion of the support arms 106 to expand and compress (e.g. in an “umbrella-like” manner).
As shown in
The support arms 106 are adjustable to move away from the axis 1800 to the expanded position, or alternatively, move towards the axis 1800 to the compressed position. The support arms 106 can have any shape or configuration (e.g. a spiral or helical configuration) which enables the support arms 106 to move between the expanded and compressed positions.
The stent 100 has a barrier portion which may include at least one barrier member 108 that is coupled to the support arms 106. The barrier member 108 may be of any material suitable to form the permeable barrier.
In one representative embodiment, the material of the barrier member 108 may be substantially non-elastic but capable of unfolding and being stretched taut to form a barrier such as occurs in a conventional umbrella arrangement. In another embodiment, the barrier member 108 may be made of a material that is elastic, and therefore can be elastically stretched to form a barrier. In yet another embodiment, the barrier member 108 may be made of a deformable (or plastic) material in the sense that upon being stretched, it may be plastically deformed to form a barrier. In a representative embodiment, the barrier member 108 is a membrane made from an elastomer material (such as silicones, latex and natural and synthetic rubbers), and/or a polymer material (such as polytetrafluoroethylene (PTFE), perfluoroalkoxy polymer resin (PFA), fluorinated ethylene-propylene (FEP), polyethylene, polyurethane). Alternatively, the barrier member 108 could be made from a metallic material (such as a nitinol, nickel or titanium alloy, or another alloy with similar elastically deformable or spring-like properties). The barrier portion of the stent 100 may include a barrier member 108 formed as a flexible or expandable mesh. For example, the barrier portion of the stent may include an adjustable mesh configuration of arms, as shown in
In these arrangements, when the support arms 106 are adjusted to the expanded position, as shown in
The barrier portion of the stent 100 defines one or more openings. For example, as shown in
In the embodiment shown in
In the embodiment shown in
In a separate embodiment of the invention, the barrier member 108 may comprise a plurality of additional arms 106 selectively positioned in the central section of the stent 100 which together form the desired barrier with openings between those arms. An example of this embodiment is the stent 100 shown in
Preferably, the openings of the barrier portion of the stent 100 are adjustable to a sufficiently large size in order to provide access to the space between the barrier and the lumen wall to enable the delivery of one or more articles (e.g. vaso-occlusive devices) in this space. The openings should also be adjustable to a size that is sufficiently small for inhibiting the one or more articles retained between the barrier and the lumen wall from moving away from this space once released into the space.
A barrier member 108 may include one or more preformed pockets 3000 for receiving and engaging a portion a particular support arm 106, as shown in
As shown in
The barrier arm portions 4300 may each be biased towards an angled position relative to the longitudinal axis 1800. Accordingly, when the support arm 106 moves in a direction indicated by direction arrow D in
As shown in
When the support arms 106 are held in position by the alignment tool 3400, the respective ends of the support arms 106 are coupled to the guide portion 102 and drive portion 104 respectively. In a representative embodiment, different ends of the support arms 106 are coupled to a different alignment member 3402 and 3404.
The alignment member 3402 also includes a connecting portion 3704 for securely engaging either a guide portion 102 or drive portion 104 of the stent 100. For example, the connection portion 3702 may be a hollow shaped for securely receiving either a guide member (of the guide portion 102) or a drive member (of the drive portion 104).
When the support arms 106 are held in position by the alignment tool 3400 and the alignment members 3402 and 3404, a crimping tube 3800 may be used for securely coupling the ends of the support arms 106 to the respective alignment members 3402 and 3404. Alternatively, the ends of the support arms 106 may be securely coupled to the respective alignment members 3402 and 3404 by means of welding, glue or other joining means or techniques.
The stent 100 is stored inside of a catheter 800 (e.g. a microcatheter) prior to use in a linearly collapsed state (as shown in
The stent 100 may include an inflatable balloon (not shown) that, during inflation, forces the arms 106 to move towards the expanded position. For example, to provide further reinforcement of the arms 106, the balloon may be placed on the drive member 104 inside the cavity surrounded by the arms 106 when in the expanded position. The balloon can also be deployed (i.e. inflated) to stop blood from flowing through the lumen 700, such as in the event of a ruptured aneurysm or other emergency.
The stent 100 may serve as an intravascular flow modifier and can provide temporary intravascular reinforcement to blood vessels that are proximate to a cerebral aneurysm. In this way, the stent will serve to divert blood flow away from the ruptured aneurysm whilst repair can be effected. The stent 100 can be used in combination with vaso-occlusive devices placed in a brain aneurysm for the purpose of occluding an aneurysm, whereby the stent 100 provides reinforcement for the area of the blood vessel in the vicinity of the aneurysm. For example, the stent 100 can be placed adjacent to the neck of an aneurysm for access and insertion of embolic coils or other devices in to the aneurysm. The stent 100 can be retrieved following the procedure, and can be later redeployed.
The steps for operating the stent 100 to retain vaso-occlusive devices in an aneurysm involves:
i) positioning the stent 100 adjacent to said aneurysm;
ii) adjusting the arms 106 to their expanded position, which stretches the barrier member 108 to form a permeable barrier adjacent to a neck portion of the aneurysm;
iii) delivering one or more vaso-occlusive devices through the permeable barrier and into the aneurysm (e.g. using delivery catheter 702), so that after the vaso-occlusive devices have been is released into the aneurysm, the barrier retains these devices within the aneurysm and inhibits these devices from moving away from the aneurysm.
The stent 100 may be delivered and left in-situ. The stent 100 may have a weakened area where the drive member (e.g. a push wire) is broken off from the drive portion 104 of the stent 100 to leave the stent 100 in place inside the lumen (e.g. after the stent 100 has been deployed).
The stent 100 may be removed by the drive member reengaging with the drive portion 104 of the stent 100 to pull the stent 100 back into the delivery tube or catheter (e.g. for removal or re-delivery at a different site). The drive member and drive portion 104 may have a portion that is correspondingly shaped for forming a releasable hooking engagement with each other. This allows the drive member to reengage with the drive portion 104 for removing the stent 100 (e.g. by pulling it back into a delivery tube or catheter) or for repositioning the stent 100 in the lumen. Once the stent 100 is fully received into the delivery tube or catheter, the stent 100 can be ejected from the delivery tube/catheter (for redeployment) using a plunger that selectively moves inside the core of the delivery tube/catheter under the control of a user.
The stent 100 is preferably made of nitinol, nickel or titanium alloy, or another alloy with similar elastically deformable or spring-like properties. The stent 100 can be made to different widths and lengths (e.g. when fully expanded).
Advantageously, the stent 100 may be potentially used in arteries up to renal size while still providing the benefits of placement without the use of balloons or mechanical expansions. One significant benefit in such an application is that the flow through the vessel is never fully occluded by the placement of the stent 100, and it is possible to place or deploy the stent 100 from a free flow guiding catheter 800 that is relatively small in diameter compared to the inside diameter of the blood vessel being treated.
While certain features of the invention and its use have been described, it will be appreciated by those skilled in the art that many forms of the invention may be used for specific applications in the medical treatment of deformations of the vasculature. Other features and advantages of the present invention would become apparent from the following detailed description taken in conjunction with the accompanying drawings, which illustrate by way of example, the principles of the invention.
As shown in the exemplary drawings, which are provided for the purposes of illustration and not by way of limitation, the device of the present invention is designed to be deployed intravascularly without the necessity of balloons or other expansive elements and can be deployed from a guiding catheter directly into the area to be treated. The intravascular device of the present invention is particularly useful for treatment of damaged arteries incorporating aneurysms and the like, particularly those which are treatable by the use of embolic coils or other embolic devices or agents used to occlude the aneurysm. More particularly, the device of the invention is particularly well adapted to use with the types of catheters used to place such embolic coils in aneurysms, and the device may be used to reinforce the area in the vicinity of the aneurysm while allowing placement of one or more embolic coils through the gaps in the stent, while assisting in the retention of the embolic devices within the dome of the aneurysm.
The invention provides numerous important advantages in the treatment of vascular malformations, and particularly malformations which include the presence of aneurysms. Since the device does not represent an essentially solid tubular member, and does not require the use of a balloon or other mechanical device for deployment, it is capable of deployment from a guiding catheter which need not occlude the artery as it is put into a position from which to deploy the device. Furthermore, the device upon deployment can reinforce the artery without occluding access to the aneurysm, thus allowing the device to be deployed prior to the placement of embolic coils or the like in the aneurysms. Alternatively, depending on the nature of the vascular defect, the embolic coils or other embolic occlusive or other vasoocclusive devices can be placed and the device deployed thereafter to hold the devices in the aneurysm.
The present invention offers a number of other advantages. For example, the stent 100 is able to provide selective reinforcement in the vicinity of the artery, while avoiding any unnecessary trauma or risk of rupture to the blood vessel, and allows retrieval of the device at the conclusion of the procedure. The stent 100 can also be temporarily deploy (for selective reinforcement device) with continuous blood flow through the lumen 700.
The stent 100 can be used to treat vascular malformations, and particularly ruptured aneurysms in the neurovasculature. Importantly, the stent 100 can be particularly useful when used in combination with vaso-occlusive devices placed in the aneurysm by intravascular procedures.
Modifications and improvements to the invention will be readily apparent to those skilled in the art. Such modifications and improvements are intended to be within the scope of this invention.
Throughout this specification and claims which follow, unless the context requires otherwise, the word “comprise”, and variations such as “comprises” and “comprising”, will be understood to imply the inclusion of a stated integer or step or group of integers or steps but not the exclusion of any other integer or step or group of integers or steps.
Filing Document | Filing Date | Country | Kind | 371c Date |
---|---|---|---|---|
PCT/AU2009/000198 | 2/20/2009 | WO | 00 | 11/4/2010 |
Number | Date | Country | |
---|---|---|---|
61064178 | Feb 2008 | US |